Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.380
-0.010 (-0.72%)
Mar 9, 2026, 2:10 PM EDT - Market open
Tiziana Life Sciences Market Cap
Tiziana Life Sciences has a market cap or net worth of $176.12 million as of March 9, 2026. Its market cap has increased by 79.39% in one year.
Market Cap
176.12M
Enterprise Value
170.25M
1-Year Change
79.39%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since October 21, 2021, Tiziana Life Sciences's market cap has increased from $145.96M to $176.12M, an increase of 20.66%. That is a compound annual growth rate of 4.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 177.40M | 0.20% |
| Dec 31, 2025 | 177.05M | 133.12% |
| Dec 31, 2024 | 75.95M | 34.82% |
| Dec 29, 2023 | 56.33M | -7.14% |
| Dec 30, 2022 | 60.66M | -35.06% |
| Dec 31, 2021 | 93.41M | -36.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 187.40M |
| Kalaris Therapeutics | 183.66M |
| Heron Therapeutics | 182.24M |
| SAB Biotherapeutics | 180.43M |
| Cartesian Therapeutics | 178.12M |
| Nkarta | 177.57M |
| Vaxart | 177.33M |
| Whitehawk Therapeutics | 176.73M |